ArticleDiabetes, obesity & metabolism2025

Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials.

Giovanni Antonio Silverii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.